250 Mg Lapatinib Tablets IP

Name: 250 Mg Lapatinib Tablets IP
Brand: NEETCO BIOPHARMA
Price: 2400 INR
Availability: InStock

Price 2400 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

250 Mg Lapatinib Tablets IP Specification

Indication
Advanced or metastatic breast cancer

Pacakaging (Quantity Per Box)
30 Tablets

Dosage Form
Solid

Origin of Medicine
Allopathic

Salt Composition
Lapatinib 250 mg

Drug Type
Prescription

Ingredients
Lapatinib

Physical Form
Tablets

Function
Anticancer agent

Recommended For
Used in treatment of breast cancer

Dosage
250 mg

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
Per box as per packaging

Storage Instructions
Store below 30C, protected from moisture and light

About 250 Mg Lapatinib Tablets IP

Sizzling effectiveness meets unbeatable quality with 250 Mg Lapatinib Tablets IP-a marvelously potent tyrosine kinase inhibitor. Specially formulated for adults, these impeccable oval yellow tablets target advanced or metastatic breast cancer. With DCGI regulatory approval, trust the precision of this prescription-required anticancer agent. Encased in secure blister packs and boasting a shelf life of 24 months, each box contains 30 tablets, ready for export and supply across India. Get it now for steadfast therapeutic action and experience the marvel of modern oncology.

Suitable Applications and Commercial Usage

Lapatinib Tablets IP 250 mg are suitable for adult patients battling advanced or metastatic breast cancer, offering unwavering efficacy in oncology care. Commercially preferred by hospitals, clinics, and pharmaceutical distributors, the tablets boast a solid dosage form ideal for regulated prescriptions. Usage follows precise physician guidelines, ensuring maximum therapeutic benefit, reliability, and safety for end users. These tablets serve as a cornerstone in cancer treatment, widely distributed by suppliers and traders across India.

FOB Port, Payment Terms, and Packaging Details

The supply of 250 Mg Lapatinib Tablets IP is facilitated through designated FOB ports across India for swift order completion. Flexible payment terms, including timely outlay options, ensure hassle-free procurement for distributors, exporters, and traders. Packaging comprises sturdy blister packs with each box containing 30 tablets, expertly sealed to protect from moisture and light. This guarantees product integrity throughout delivery and storage, making each order a seamless experience for all commercial stakeholders.

FAQ's of 250 Mg Lapatinib Tablets IP:

Q: How should the 250 Mg Lapatinib Tablets IP be stored to maintain efficacy?

A: Store these tablets below 30C, protected from moisture and light, in their original blister packaging to ensure optimal efficacy and shelf life.

Q: What is the therapeutic benefit of taking Lapatinib Tablets IP?

A: Lapatinib Tablets IP provide targeted therapy for advanced or metastatic breast cancer, working as a tyrosine kinase inhibitor to block cancer cell growth.

Q: When is 250 Mg Lapatinib Tablets IP prescribed to patients?

A: Physicians prescribe this medication to adults diagnosed with advanced or metastatic breast cancer, following dose guidelines specific to individual cases.

Q: Where are Lapatinib Tablets IP manufactured and distributed?

A: These tablets are manufactured in India and are distributed through approved suppliers, exporters, and traders, adhering to DCGI regulatory standards.

Q: What is the process for commercial supply and order completion?

A: Orders for Lapatinib Tablets IP are fulfilled via FOB ports, with negotiated payment terms and secure blister packaging for reliable and timely delivery to commercial clients.

Q: How should patients use Lapatinib Tablets IP for best results?

A: Patients must follow dosage instructions exactly as directed by their physician and report any side effects such as diarrhea, rash, nausea, or fatigue.

Tell us about your requirement